Table 2.
Evaluation of the serum levels of malondialdehyde, total anti-oxidant capacity, LH, FSH, and testosterone in different experimental groups after 180 days of treatment
| Groups | MDA (nmol/ml) | TAC (IU/ml) | LH (IU/ml) | FSH (IU/ml) | TES (nmol/L) |
|---|---|---|---|---|---|
| Control | 0.44±0.01 | 0.33±0.05 | 22.95±3.27 | 24.28±3.98 | 95.28±4.24 |
| Sham | 0.42±0.01 | 0.32±0.03 | 23.45±2.62 | 26.12±2.53 | 95.4±8.26 |
| LC 200 | 0.03±0.02 | 0.34±0.05 | 23.12±3.67 | 26.45±2.71 | 97.31±2.92 |
| MSG | 1.12±0.04*** | 0.10±0.05*** | 10.33±2.58*** | 12.00±6.41*** | 38.24±4.34*** |
| MSG+LC 100 | 0.50±0.31††† | 0.18±0.04*** | 14.66±1.86*** | 15.00±5.93*** | 52.08±6.63***† |
| MSG+LC 200 | 0.24±0.12†††$ | 0.29±0.05***$$ | 18.83±1.16††† | 20.83±6.89† | 71.66±11.27***†††$$$ |
Data are presented as mean±SEM, n=10
*Compare to sham group; † MSG compare to MSG+LC100 and MSG+LC200 groups; $ MSG+LC100 compare to MSG+LC200. P<0.05 considered as significant changes
MDA malondialdehyde, TAC total anti-oxidant capacity, TES testosterone, LH luteinizing hormone, FSH follicle-stimulating hormone